Furthermore, CYR61 is involved in inflammatory and fibrotic responses, which can create a tumor-promoting microenvironment; targeting CYR61 can thus alter this microenvironment to be less supportive of cancer progression [21,22]. This evidence concerns the gene CCN1 and cancer.